JF
Johanna Friedl-Naderer sold $4K of DYN stock
Johanna Friedl-Naderer, Chief Commercial Officer of Dyne Therapeutics, Inc. (DYN), sold 231 shares of DYN stock worth $4K, per an SEC Form 4 filed Nov 16, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 13, 2026, 3 days before it was made public.
DYN has moved -6.6% since the trade date, from $17.16 to $16.03 (Nov 19, 2026 close).
- Traded
- Nov 13, 2026
- Disclosed
- Nov 16, 2026
- Filing delay
- 3 days
- Price since
- -6.6%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4